文摘
Routine screening for human PPAR ligands yielded compounds 1 and 2, both of which were sub-micromolar hPPAR?? agonists. Synthetic modifications of these leads led to a series of potent substituted 3-benzyl-2-methyl indoles, a subset of which were noted to be selective PPAR?? modulators (SPPAR??Ms). SPPAR??M 24 displayed robust anti-diabetic activity with an improved therapeutic window in comparison to a PPAR?? full agonist in a rodent efficacy model.